The Resource Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden
Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden
Resource Information
The item Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in University of Missouri-Kansas City Libraries.This item is available to borrow from 1 library branch.
Resource Information
The item Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in University of Missouri-Kansas City Libraries.
This item is available to borrow from 1 library branch.
- Summary
- "Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"--Provided by publisher
- Language
- eng
- Extent
- xi, 524 pages
- Contents
-
- Introduction
- The FDA's regulation of prescription drugs and devices
- Pre-litigation counseling
- Legal issues & theories
- Consolidated proceedings
- Aggregated proceedings
- Class actions
- Aggregated proceedings
- Multidistrict litigation
- Fact discovery
- Expert retention and discovery
- Expert testimony, Rule 702, And Daubert
- Preemption
- The learned intermediary doctrine
- Motions In limine
- Jury selection
- The trial of a drug or device case
- Isbn
- 9780199734948
- Label
- Drug and device product liability litigation strategy
- Title
- Drug and device product liability litigation strategy
- Statement of responsibility
- Mark Herrmann, David B. Alden
- Subject
-
- Equipment and Supplies
- LAW / General
- LAW / Litigation
- LAW / Medical Law & Legislation
- Legislation, Drug
- Consumer Product Safety -- legislation & jurisprudence
- Products liability -- Drugs -- United States -- Trial practice
- Products liability -- Medical instruments and apparatus -- United States -- Trial practice
- United States
- Liability, Legal
- Language
- eng
- Summary
- "Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"--Provided by publisher
- Cataloging source
- DLC
- http://library.link/vocab/creatorName
- Herrmann, Mark
- Dewey number
- 346.7303/8
- Index
- index present
- LC call number
- KF8925.P7
- LC item number
- H47 2012
- Literary form
- non fiction
- Nature of contents
- bibliography
- NLM call number
-
- 2012 A-313
- W 44 AA1
- http://library.link/vocab/relatedWorkOrContributorName
- Alden, David B
- http://library.link/vocab/subjectName
-
- Products liability
- Products liability
- Liability, Legal
- Consumer Product Safety
- Equipment and Supplies
- Legislation, Drug
- United States
- United States
- LAW / General
- LAW / Litigation
- LAW / Medical Law & Legislation
- Label
- Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden
- Bibliography note
- Includes bibliographical references and index
- Carrier category
- volume
- Carrier category code
-
- nc
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Introduction -- The FDA's regulation of prescription drugs and devices -- Pre-litigation counseling -- Legal issues & theories -- Consolidated proceedings -- Aggregated proceedings -- Class actions -- Aggregated proceedings -- Multidistrict litigation -- Fact discovery -- Expert retention and discovery -- Expert testimony, Rule 702, And Daubert -- Preemption -- The learned intermediary doctrine -- Motions In limine -- Jury selection -- The trial of a drug or device case
- Control code
- 727704983
- Dimensions
- 24 cm
- Extent
- xi, 524 pages
- Isbn
- 9780199734948
- Isbn Type
- (pbk.)
- Lccn
- 2011024678
- Media category
- unmediated
- Media MARC source
- rdamedia
- Media type code
-
- n
- System control number
- (OCoLC)727704983
- Label
- Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden
- Bibliography note
- Includes bibliographical references and index
- Carrier category
- volume
- Carrier category code
-
- nc
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Introduction -- The FDA's regulation of prescription drugs and devices -- Pre-litigation counseling -- Legal issues & theories -- Consolidated proceedings -- Aggregated proceedings -- Class actions -- Aggregated proceedings -- Multidistrict litigation -- Fact discovery -- Expert retention and discovery -- Expert testimony, Rule 702, And Daubert -- Preemption -- The learned intermediary doctrine -- Motions In limine -- Jury selection -- The trial of a drug or device case
- Control code
- 727704983
- Dimensions
- 24 cm
- Extent
- xi, 524 pages
- Isbn
- 9780199734948
- Isbn Type
- (pbk.)
- Lccn
- 2011024678
- Media category
- unmediated
- Media MARC source
- rdamedia
- Media type code
-
- n
- System control number
- (OCoLC)727704983
Subject
- Equipment and Supplies
- LAW / General
- LAW / Litigation
- LAW / Medical Law & Legislation
- Legislation, Drug
- Consumer Product Safety -- legislation & jurisprudence
- Products liability -- Drugs -- United States -- Trial practice
- Products liability -- Medical instruments and apparatus -- United States -- Trial practice
- United States
- Liability, Legal
Library Links
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.umkc.edu/portal/Drug-and-device-product-liability-litigation/gta0reILJeY/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.umkc.edu/portal/Drug-and-device-product-liability-litigation/gta0reILJeY/">Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.umkc.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.umkc.edu/">University of Missouri-Kansas City Libraries</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Item Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.umkc.edu/portal/Drug-and-device-product-liability-litigation/gta0reILJeY/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.umkc.edu/portal/Drug-and-device-product-liability-litigation/gta0reILJeY/">Drug and device product liability litigation strategy, Mark Herrmann, David B. Alden</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.umkc.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.umkc.edu/">University of Missouri-Kansas City Libraries</a></span></span></span></span></div>
